Insider Buying: Health Catalyst (NASDAQ:HCAT) CEO Buys $105,610.00 in Stock

Health Catalyst, Inc. (NASDAQ:HCAT) CEO Simeon Kohl acquired 59,000 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The shares were purchased at an average price of $1.79 per share, with a total value of $105,610.00. Following the acquisition, the chief executive officer owned 2,856,385 shares of the company’s stock, valued at approximately $5,112,929.15. This trade represents a 2.11% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Health Catalyst Trading Down 1.4%

HCAT opened at $1.77 on Friday. The firm’s fifty day moving average is $1.89 and its two-hundred day moving average is $1.64. The firm has a market cap of $133.59 million, a PE ratio of -0.48 and a beta of 1.53. Health Catalyst, Inc. has a twelve month low of $0.96 and a twelve month high of $3.62. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.70 and a current ratio of 2.70.

Health Catalyst (NASDAQ:HCAT) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.04 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. Health Catalyst had a negative net margin of 90.61% and a negative return on equity of 1.83%. The business had revenue of $70.49 million during the quarter, compared to analysts’ expectations of $69.09 million. Equities research analysts anticipate that Health Catalyst, Inc. will post -0.18 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Palogic Value Management L.P. bought a new stake in Health Catalyst during the 2nd quarter worth about $9,796,000. Whetstone Capital Advisors LLC grew its holdings in shares of Health Catalyst by 0.5% in the 4th quarter. Whetstone Capital Advisors LLC now owns 3,750,377 shares of the company’s stock valued at $8,963,000 after acquiring an additional 19,027 shares in the last quarter. BlackRock Inc. acquired a new stake in shares of Health Catalyst in the second quarter valued at about $3,654,000. Hsbc Holdings PLC acquired a new stake in shares of Health Catalyst in the second quarter valued at about $809,000. Finally, Squarepoint Ops LLC boosted its position in Health Catalyst by 1,214.8% during the second quarter. Squarepoint Ops LLC now owns 400,210 shares of the company’s stock valued at $796,000 after purchasing an additional 369,772 shares during the last quarter. Institutional investors own 85.00% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on HCAT shares. Citigroup reduced their target price on shares of Health Catalyst from $2.50 to $2.00 and set a “neutral” rating for the company in a research note on Tuesday, August 11th. Wells Fargo & Company cut their price target on Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating on the stock in a report on Thursday, August 13th. Weiss Ratings raised Health Catalyst from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, July 28th. Finally, Canaccord Genuity Group reiterated a “hold” rating and set a $1.80 price objective (down from $3.00) on shares of Health Catalyst in a report on Thursday, August 20th. Three investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $2.45.

Health Catalyst Company Profile

Health Catalyst, Inc is a healthcare technology and data analytics company that helps healthcare organizations use data to improve clinical outcomes, operational performance and financial results. The company provides software, data management capabilities and professional services designed to support hospitals, health systems, medical groups and other healthcare providers.

Its offerings include the Health Catalyst Data Operating System, which integrates and organizes data from disparate clinical, financial and operational systems, as well as analytics applications for areas such as quality improvement, population health, cost management and care delivery.